Matches in Wikidata for { <http://www.wikidata.org/entity/Q93050495> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q93050495 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q93050495 description "scientific article published on 01 December 2019" @default.
- Q93050495 description "wetenschappelijk artikel" @default.
- Q93050495 description "наукова стаття, опублікована 1 грудня 2019" @default.
- Q93050495 name "Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma" @default.
- Q93050495 name "Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma" @default.
- Q93050495 type Item @default.
- Q93050495 label "Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma" @default.
- Q93050495 label "Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma" @default.
- Q93050495 prefLabel "Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma" @default.
- Q93050495 prefLabel "Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma" @default.
- Q93050495 P1433 Q93050495-109BD24C-DFFE-4515-97C1-5F8111F1E18A @default.
- Q93050495 P1476 Q93050495-FCF84D35-2B19-417A-84CC-166E6C8F43AE @default.
- Q93050495 P2093 Q93050495-04E839FC-D7F0-4425-8DD9-AF291E793DE2 @default.
- Q93050495 P2093 Q93050495-25F710E2-5AA0-46FC-A6CB-E6C827ECF47A @default.
- Q93050495 P2093 Q93050495-73760EC0-F956-4581-8FB6-85805E7915E5 @default.
- Q93050495 P2093 Q93050495-E24F6CF5-B336-4F28-84A1-607E6F4B4CE9 @default.
- Q93050495 P275 Q93050495-91BCFBFE-E713-469A-991C-C88E1ECB6274 @default.
- Q93050495 P304 Q93050495-5E8786B5-3566-43E1-8069-43E9158DADB4 @default.
- Q93050495 P31 Q93050495-9EE9870C-3DB4-45B9-9F9F-55D83CCA3308 @default.
- Q93050495 P356 Q93050495-66CF240B-8583-41A3-A220-6652FF67D7A1 @default.
- Q93050495 P433 Q93050495-7988EE86-C0EA-431C-A093-C10FC282A7E8 @default.
- Q93050495 P478 Q93050495-EEAC666E-74B3-4C4C-ACA7-1FCFE23100CE @default.
- Q93050495 P577 Q93050495-708E7913-6225-4472-81A3-FA67508192A1 @default.
- Q93050495 P6216 Q93050495-5F1DABE3-E1B7-4ED5-93D7-D85D63245A81 @default.
- Q93050495 P698 Q93050495-2A073607-0D32-4C4A-8CFB-0825A5416EF7 @default.
- Q93050495 P921 Q93050495-2AA23ECC-CC23-4A9B-BA1C-CC5234291549 @default.
- Q93050495 P356 21691401.2019.1596943 @default.
- Q93050495 P698 30977418 @default.
- Q93050495 P1433 Q27724536 @default.
- Q93050495 P1476 "Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma" @default.
- Q93050495 P2093 "Na Zhang" @default.
- Q93050495 P2093 "Tianqi Wang" @default.
- Q93050495 P2093 "Yao Yao" @default.
- Q93050495 P2093 "Yongjun Liu" @default.
- Q93050495 P275 Q20007257 @default.
- Q93050495 P304 "1374-1383" @default.
- Q93050495 P31 Q13442814 @default.
- Q93050495 P356 "10.1080/21691401.2019.1596943" @default.
- Q93050495 P433 "1" @default.
- Q93050495 P478 "47" @default.
- Q93050495 P577 "2019-12-01T00:00:00Z" @default.
- Q93050495 P6216 Q50423863 @default.
- Q93050495 P698 "30977418" @default.
- Q93050495 P921 Q1148337 @default.